Table 4. Relative Abundance of Bacterial Phyla in Blood and Stool Samples from ME/CFS Patients and Health Controls.
Blood Samples a | Stool Samples b | |||
---|---|---|---|---|
Phyla | ME/CFS Patients | Controls | ME/CFS Patients | Controls |
Actinobacteria | 10.52% | 10.80% | 0.58% c | 1.06% |
Bacteroidetes | 17.84% | 22.38% | 27.71% | 22.43% |
Firmicutes | 9.52% | 7.89% | 58.40% | 65.29% |
Other | 7.97% | 8.55% | 9.71% | 9.11% |
Proteobacteria | 54.14% | 50.38% | 3.59% | 2.12% |
ME/CFS, myalgic encephalomyelitis/chronic fatigue syndrome.
a Mean relative abundance for 10 case and 10 control samples collected at baseline and 15 min, 48 hours, and 72 hours post-exercise challenge.
b Mean relative abundance for 10 case and 10 control samples collected at baseline and 48 and 72 hours post-exercise challenge.
c Significantly different from control (p < 0.05)